Dynamics of anti-RBD (anti-receptor binding domain) levels in diabetes patients following the ChAdOx1 nCoV-19 vaccine (AZD1222) in the Thai population.

Sci Rep · 2023 · PMC10361991 · PMID 37479776

Europe PMC DOI

hedged sentence

0.2120

closest p · 4.2× alpha

0.2120

boldest claim

The sentences

did not reach statistical significanceP = 0.212not close (p > 0.1)

In the diabetic group, the GMC of anti-RBD antibody levels at T2 (24.68 BAU/mL, 95% CI 16.43–37.09) tended to be higher than at T1 (17.05 BAU/mL, 95% CI 11.10–26.19) after the first vaccination but this did not reach statistical significance ( P = 0.212).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.